Literature DB >> 31626966

Exploring mechanochemical parameters using a DoE approach: Crystal structure solution from synchrotron XRPD and characterization of a new praziquantel polymorph.

Debora Zanolla1, Beatrice Perissutti2, Paolo Cerreia Vioglio3, Michele R Chierotti4, Lara Gigli5, Nicola Demitri5, Nadia Passerini6, Beatrice Albertini6, Erica Franceschinis7, Jennifer Keiser8, Dario Voinovich1.   

Abstract

A rotated Doehlert matrix was utilized to explore the experimental design space around the milling parameters of Praziquantel (PZQ) polymorph B formation in terms of frequency and milling time. Three experimental responses were evaluated on the resulting ground samples: two quantitative responses, i.e. median particle size by Laser Light scattering (LLS) and drug recovery by HPLC, and one qualitative dependent variable, i.e. the obtained PZQ crystalline form, characterized through X-Ray Powder Diffraction (XRPD) and confirmed by Differential Scanning Calorimetry (DSC) and Thermogravimetric analysis (TGA). Temperature inside the jars was kept under constant control during the milling process by using temperature sensor equipped jars (thermojars), thus allowing evaluation of the obtained solid states at each experimental point, considering the specific temperature of the process. This explorative analysis led to the finding of a novel PZQ polymorph, named "Form C", produced without degradation, then fully characterized, including by means of Synchrotron XRPD, Polarimetric, FT-IR, SS-NMR, ESEM and saturation solubility. Crystal structure was solved from XRPD data and its geometry was optimized by DFT calculations (CASTEP). Finally, Form C and Form A activity against adult schistosoma mansoni were compared through in vitro testing, and Form C's physical stability checked. The new polymorph, crystallizing in space group I2/c, physically stable for approximately 2 months, showed a m.p. of 106.84 °C and displayed excellent biopharmaceutical properties (water solubility of 382.69±9.26 mg/l), while preserving excellent activity levels against adult schistosoma mansoni.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crystal structure solution; Crystalline polymorph; Doehlert design; Mechanochemistry; Praziquantel; Solubility; Thermojars

Year:  2019        PMID: 31626966     DOI: 10.1016/j.ejps.2019.105084

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  3 in total

Review 1.  Better and greener: sustainable pharmaceutical manufacturing technologies for highly bioavailable solid dosage forms.

Authors:  Serena Bertoni; Dritan Hasa; Beatrice Albertini; Beatrice Perissutti; Mario Grassi; Dario Voinovich; Nadia Passerini
Journal:  Drug Deliv Transl Res       Date:  2022-01-06       Impact factor: 5.671

2.  Cocrystals of Praziquantel: Discovery by Network-Based Link Prediction.

Authors:  Jan-Joris Devogelaer; Maxime D Charpentier; Arnoud Tijink; Valérie Dupray; Gérard Coquerel; Karen Johnston; Hugo Meekes; Paul Tinnemans; Elias Vlieg; Joop H Ter Horst; René de Gelder
Journal:  Cryst Growth Des       Date:  2021-05-20       Impact factor: 4.076

3.  Mechanochemical Formation of Racemic Praziquantel Hemihydrate with Improved Biopharmaceutical Properties.

Authors:  Debora Zanolla; Dritan Hasa; Mihails Arhangelskis; Gabriela Schneider-Rauber; Michele R Chierotti; Jennifer Keiser; Dario Voinovich; William Jones; Beatrice Perissutti
Journal:  Pharmaceutics       Date:  2020-03-23       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.